These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 6382519
1. Monoclonal antibody 791T/36 for tumor detection and therapy for metastases. Baldwin RW, Pimm MV, Embleton MJ, Armitage NM, Farrands PA, Hardcastle JD, Perkins A. Symp Fundam Cancer Res; 1983; 36():437-55. PubMed ID: 6382519 [No Abstract] [Full Text] [Related]
2. Experience in the preparation and experimental use of immunocytostatics. Embleton MJ, Pimm MV, Garnett MC, Rowland GF, Simmonds RG, Baldwin RW. Behring Inst Mitt; 1984 May; (74):108-12. PubMed ID: 6591915 [Abstract] [Full Text] [Related]
3. Mechanisms of tumor growth inhibition. Steplewski Z, Herlyn D, Lubeck M, Kimoto Y, Herlyn M, Koprowski H. Hybridoma; 1986 Jul; 5 Suppl 1():S59-64. PubMed ID: 3744386 [No Abstract] [Full Text] [Related]
12. Vindesine as a single agent and in combination with adriamycin in the treatment of metastatic breast carcinoma. Smith IE, Coombes RC, Evans BD, Ford HT, Gazet JC, Gordon C, McKinna JA, Powles TJ. Eur J Cancer (1965); 1980 Mar; Suppl 1():271-3. PubMed ID: 7032939 [No Abstract] [Full Text] [Related]
16. Vindesine in the treatment of advanced colorectal cancer: a phase II study. Diaz-Rubio E, Martin-Jimenez M. Cancer Treat Rep; 1984 Mar; 68(3):555-6. PubMed ID: 6704985 [No Abstract] [Full Text] [Related]
18. Antitumor properties of vindesine-monoclonal antibody conjugates. Rowland GF, Axton CA, Baldwin RW, Brown JP, Corvalan JR, Embleton MJ, Gore VA, Hellström I, Hellström KE, Jacobs E. Cancer Immunol Immunother; 1985 Mar; 19(1):1-7. PubMed ID: 3844970 [Abstract] [Full Text] [Related]